tradingkey.logo
搜索

ICON PLC

ICLR
添加自选
163.455USD
+5.285+3.34%
交易中 美东报价延迟15分钟
12.52B总市值
21.90市盈率 TTM

ICON PLC

163.455
+5.285+3.34%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+3.34%

5天

+14.09%

1月

+39.97%

6月

-11.01%

今年开始到现在

-10.30%

1年

+10.04%

关键数据
161.920今开
168.630最高
587.83K成交量
21.90市盈率 TTM
14.34市盈率动
--股息TTM
0.77%换手率
158.170昨收
161.415最低
74.28M成交额
15.82市盈率静
1.35市净率
0.00%股息率 TTM
3.56%ROA
211.00052周最高
1.52量比
791.47M净利润
76.60M总股本
7.4645每股收益TTM
1.26Beta
6.27%ROE
66.57052周最低
4.56%振幅
19.06%毛利率
12.52B总市值
12.32回报/风险
3.16%风险率

TradingKey ICON PLC股票评分

单位: USD 更新时间: 2026-06-24

操作建议

ICON PLC当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名20/388位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价160.13。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

ICON PLC评分

相关信息

行业排名
20 / 388
全市场排名
72 / 4571
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

ICON PLC亮点

亮点风险
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
行业龙头
公司营业收入处于行业前列,最新年度总收入8.25B美元
估值合理
公司最新PE估值21.19,处于3年历史合理位
机构减仓
最新机构持股83.08M股,环比减少15.66%

分析师目标

根据 18 位分析师
买入
评级
160.133
目标均价
+9.68%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

ICON PLC新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

ICON PLC简介

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
公司代码ICLR
公司ICON PLC
CEOBalfe (Barry Edward)
网址https://www.iconplc.com/

常见问题

ICON PLC(ICLR)的当前股价是多少?

ICON PLC(ICLR)的当前股价是 158.17。

ICON PLC的股票代码是什么?

ICON PLC的股票代码是ICLR。

ICON PLC股票的52周最高点是多少?

ICON PLC股票的52周最高点是211.00。

ICON PLC股票的52周最低点是多少?

ICON PLC股票的52周最低点是66.57。

ICON PLC的市值是多少?

ICON PLC的市值是12.12B。

现在ICON PLC(ICLR)的股票是买入、持有还是卖出?

根据分析师评级,ICON PLC(ICLR)的总体评级为买入,目标价格为160.13。

ICON PLC(ICLR)股票的每股收益(EPS TTM)是多少

ICON PLC(ICLR)股票的每股收益(EPS TTM)是2.92。
KeyAI